Skip to main content
Online CJC-1295

An accessible, plain-language digest of what the published CJC-1295 research actually shows on the growth-hormone / IGF-1 axis - laid out as a curated board of the studies, the kinetics, and the honest data gaps.

What each study found, one by one

CJC-1295 research, with the limits kept in view

You’ll see who took part, what changed, and why blood-test results can’t promise a health gain for you.

How does the drug raise IGF-1, the insulin-like growth factor?

Scientists built CJC-1295 from small protein pieces; this kind of chain is called a peptide. It makes cells in the growth gland send more growth hormone into blood [1][2]. This page takes you through the main work in people and animals. Your liver then makes IGF-1, short for insulin-like growth factor, a hormone used in growth [1].

Scientists changed four protein parts so CJC-1295 wouldn’t break apart too soon. The long form also latches onto albumin, a protein that travels in blood [2]. One small study found that men kept their usual brief releases of growth hormone [3]. In plain terms, the men’s normal bursts didn’t become a constant flow.

What happened in the main CJC-1295 adult study?

The clearest human result came from healthy adults ages 21 to 61. Their shots held 30 or 60 micrograms for each kilogram they weighed [1]. One gram holds a million micrograms. Average growth hormone climbed 2- to 10-fold, or two to ten times the starting level.

IGF-1 rose 1.5- to 3-fold and stayed high for the next nine to eleven days. After more shots, IGF-1 was still high on day 28. The body needed about 5.8 to 8.1 days to clear half of CJC-1295. A 2006 study found these changes; another 2006 study checked brief hormone releases, and a 2009 study checked blood proteins [3][4].

Here’s where I’d pause. These were small studies of blood tests, not proof that you’d feel better. They can’t tell you whether years of use would be safe. A large change on a blood test still isn’t the same as better health for you.

What happened in the main CJC-1295 adult study?

How quickly did IGF-1 rise?

The change appeared within one week. Healthy men ages 20 to 40 got one CJC-1295 shot holding 60 or 90 micrograms per kilogram. Their lowest growth-hormone reading rose about 7.5-fold, or about seven-and-a-half times. Average growth hormone rose 46%, while IGF-1, the insulin-like growth factor, rose 45% [3].

While IGF-1 rose, the men still had the same number and size of brief hormone releases [3]. Earlier work found a larger release when the gland got breaks between requests, rather than one request that never stopped [6]. So the long form didn’t turn the men’s usual bursts into a steady flow. It still can’t tell you how they felt or predict your result.

What changed with CJC-1295 and IGF-1?

Growth hormone rose first, then IGF-1, the insulin-like growth factor, followed. One week after a 60-90 micrograms per kilogram shot, IGF-1 was 45% higher [3]. After more shots, IGF-1 stayed high through the 28-day mark [1]. The groups were small, so you can’t count on the same IGF-1 result in your blood.

A separate study tested 11 healthy young men who received CJC-1295. Blood tests found less of two proteins that carry fat and thyroid hormone. Small pieces of albumin and proteins that help your immune system work also increased [4]. Researchers didn’t know whether those blood changes were good or bad for the men, and the study didn’t show more strength, less fat, or any other health benefit you could feel in daily life.

Why did the long form remain in blood?

The best early answer came from rats. Researchers made the short CJC-1295 1-29 form join the blood protein albumin. Across two hours, growth hormone was 4-fold higher than with the free 1-29 form. The joined form could still be found after 72 hours [2].

Albumin made the rats clear CJC-1295 more slowly. This was work in animals and a lab, so it can’t show that you’d benefit. It explains only why the long form lasts longer. The long-form page tells you what that timing can and can’t mean for your health.

What happened in mice that lacked the first hormone?

This result came only from mice. Their bodies couldn’t make the hormone that starts the growth-gland process. With 2 micrograms of CJC-1295 every 24 hours, the mice returned to normal weight and normal length [7]. Giving it every 48 or 72 hours worked less well.

A gene, which is a cell’s set of instructions, became more active in their growth glands. That gene helps the gland make growth hormone. The result shows that the drug acted as planned in those mice. It can’t predict what you’d feel, how your body would react, or what would happen in a healthy person.

Why test CJC-1295 beside ipamorelin?

Ipamorelin is another test drug made from small protein parts. It reaches the growth gland in its own way. Lab work found more hormone when both drugs were present than when either was used alone [5]. That result is a reason to keep studying the pair.

Now the part that matters to you. No fair study in people has shown that the CJC-1295 and ipamorelin pair improves health in healthy adults. The dosing schedules you see online weren’t taken from such a trial. Until that study exists, you don’t know whether the pair helps, harms, or changes anything you can feel.

What does “CJC-1295 ipamorelin” refer to?

The words CJC-1295 and ipamorelin name two test drugs used as a pair. Both are small chains of protein parts. They reach your growth gland by separate routes [5]. Lab work found a larger effect when both were present. No controlled human study has shown that the pair would improve your health.

Has CJC-1295 with ipamorelin helped people in a study?

No study in people has answered the question. Lab work found a larger growth-hormone release with both peptides present [5]. That finding can’t show that sleep, strength, or health improves in a person. When someone makes you a firm promise, the human study you need still isn’t there, so you can’t know your likely result.

What did the CJC-1295 studies measure?

The strongest findings are blood and growth changes. In people, growth hormone and IGF-1 stayed higher for days while the usual short releases continued [1][3]. In rats, the long form produced a 4-fold rise in total growth hormone [2]. Mice that lacked the starting hormone returned to normal growth [7].

Those results don’t prove fat loss, better sports results, or slower aging in healthy people. You can accept what was measured without adding a claim the studies never tested for you or your health. That’s the fair reading of CJC-1295.

Can CJC-1295 studies predict how you’ll feel?

Small human studies showed growth hormone and IGF-1, the insulin-like growth factor, staying higher for days [1][3]. They didn’t show what one person felt. The work lasted weeks, not years. A blood-test change can’t promise a change in your daily life.

No regulator has cleared CJC-1295 for people. The human results tell you only what changed in blood. The animal results answer separate questions about growth and timing. When you weigh the findings, give those limits the same weight in your decision.